Human and yeast Cdk-activating kinases (CAKs) display distinct substrate specificities

Molecular Biology of the Cell

Volumn 9, Issue 9, 1998, Pages 2545-2560

  Kaldis, Philipp ^a   Russo, Alicia A ^b   Chou, Hubert S ^d   Pavletich, Nikola P ^b,c   Solomon, Mark J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; PROTEIN KINASE; RNA POLYMERASE II;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME SPECIFICITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SPECIES DIFFERENCE; YEAST;

SACCHAROMYCETALES;

EID: 0031686960     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.9.9.2545     Document Type: Article

References (79)

1. Adamczewski, J.P., Rossignol, M., Tassan, J.-P., Nigg, E.A., Moncollin, V., and Egly, J.-M. (1996). MAT1, cdk7 and cyclin H form a kinase complex which is UV light-sensitive upon association with TFIIH. EMBO J. 15, 1877-1884.
2. Aprelikova, O., Xiong, Y., and Liu, E.T. (1995). Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase. J. Biol. Chem. 270, 18195-18197.
3. Kip1 with cyclin A-cdk2 and cyclin D2-cdk4. J. Biol. Chem. 272, 25863-25872.
4. Canagarajah, B.J., Khokhlatchev, A., Cobb, M.H., and Goldsmith, E.J. (1997). Activation mechanism of the MAP kinase ERK2 by dual phosphorylation. Cell 90, 859-869.
5. ink4. Mol. Cell. Biol. 15, 2682-2688.
6. CIP1. Mol. Cell. Biol. 16, 4673-4682.
7. Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction. Oncogene 12, 595-607.
8. Chun, K.T., and Goebl, M.G. (1997). Mutational analysis of Cak1p, an essential protein kinase that regulates cell cycle progression. Mol. Gen. Genet. 256, 365-375.
9. Cismowski, M.J., Laff, G.M., Solomon, M.J., and Reed, S.I. (1995). KIN28 encodes a C-terminal domain kinase that controls mRNA transcription in Saccharomyces cerevisiae but lacks cyclin-dependent kinase-activating kinase (CAK) activity. Mol. Cell. Biol. 15, 2983-2992.
10. Connell-Crowley, L., Solomon, M.J., Wei, N., and Harper, J.W. (1993). Phosphorylation independent activation of human cyclin-dependent kinase 2 by cyclin A in vitro. Mol. Biol. Cell 4, 79-92.
11. De Bondt, H.L., Rosenblatt, J., Jancarik, J., Jones, H.D., Morgan, D.O., and Kim, S.-H. (1993). Crystal structure of cyclin-dependent kinase 2. Nature 363, 595-602.
12. Devault, A., Martinez, A.-M., Fesquet, D., Labbé, J.-C., Morin, N., Tassan, J.-P., Nigg, E.A., Cavadore, J.-C., and Dorée, M. (1995). MAT1 ('menage à trois') a new RING finger protein subunit stabilizing cyclin H-cdk7 complexes in starfish and Xenopus CAK. EMBO J. 14, 5027-5036.
13. Diehl, J.A., and Sherr, C.J. (1997). A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase. Mol. Cell. Biol. 17, 7362-7374.
14. El-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, E., Kinzler, K.W., and Vogelstein, B. (1993). WAF1, a potent mediator of p53 tumor suppression. Cell 75, 817-825.
15. Elledge, S.J., and Spottswood, M.R. (1991). A new human p34 protein kinase, CDK2, identified by complementation of a cdc28 mutation in Saccharomyces cerevisiae, is a homolog of Xenopus Eg1. EMBO J. 10, 2653-2659.
16. Espinoza, F.H., Farrell, A., Erdjument-Bromage, H., Tempst, P., and Morgan, D.O. (1996). A cyclin-dependent kinase-activating kinase (CAK) in budding yeast unrelated to vertebrate CAK. Science 273, 1714-1717.
17. Evans, T., Rosenthal, E.T., Youngblom, J., Distel, D., and Hunt, T. (1983). Cyclin: a protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division. Cell 33, 389-396.
18. Feaver, W.J., Svejstrup, J.Q., Henry, N.L., and Kornberg, R.D. (1994). Relationship of CDK-activating kinase and RNA polymerase II CTD kinase TFIIH/TFIIK. Cell 79, 1103-1109.
19. Fesquet, D., Labbé, J.-C., Derancourt, J., Capony, J.-P., Galas, S., Girard, F., Lorca, T., Shuttleworth, J., Dorée, M., and Cavadore, J.-C. (1993). The MO15 gene encodes the catalytic subunit of a protein kinase that activates cdc2 and other cyclin-dependent kinases (CDKs) through phosphorylation of Thr161 and its homologues. EMBO J. 12, 3111-3121.
20. Fesquet, D., Morin, N., Dorée, M., and Devault, A. (1997). Is cdk7/cyclin H/MAT1 the genuine cdk activating kinase in cycling Xenopus egg extracts? Oncogene 15, 1303-1307.
21. Fisher, R.P., and Morgan, D.O. (1994). A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell 78, 713-724.
22. Fisher, R.P., Jin, P., Chamberlin, H.M., and Morgan, D.O. (1995). Alternative mechanisms of CAK assembly require an assembly factor or an activating kinase. Cell 83, 47-57.
23. Gu, Y., Turck, C.W., and Morgan, D.O. (1993). Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366, 707-710.
24. INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev. 8, 2939-2952.
25. Hanks, S.K., and Quinn, A.M. (1991). Protein kinase catalytic domain sequence database: identification of conserved features of primary structure and classification of family members. Methods Enzymol. 200, 38-62.
26. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371, 257-261.
27. Harper, J.W., Adami, G.R., Wei, N., Keyomarski, K., and Elledge, S.J. (1993). The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816.
28. Hemmer, W., McGlone, M., Tsigelny, I., and Taylor, S.S. (1997). Role of the glycine triad in the ATP-binding site of cAMP-dependent protein kinase. J. Biol. Chem. 272, 16946-16954.
29. Hirai, H., Roussel, M.F., Kato, J.-Y., Ashmun, R.A., and Sherr, C.J. (1945). Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol. 15, 2672-2681.
30. Iavarone, A., and Massagué, J. (1997). Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p15. Nature 387, 417-422.
31. Inamoto, S., Segil, N., Pan, Z.-Q., Kimura, M., and Roeder, R.G. (1997). The cyclin-dependent kinase-activating kinase (CAK) assembly factor, MAT1, targets and enhances CAK activity on the POU domains of octamer transcription factors. J. Biol. Chem. 272, 29852-29858.
32. Jeffery, P.D., Russo, A.A., Polyak, K., Gibbs, E., Hurwitz, J., Massagué, J., and Pavletich, N.P. (1995). Mechanism of cdk activation revealed by the structure of a cyclin A-CDK2 complex. Nature 376, 313-320.
33. Johnson, L.N., Noble, M.E.M., and Owen, D.J. (1996). Active and inactive protein kinases: structural basis for regulation. Cell 85, 149-158.
34. Kaldis, P., Sutton, A., and Solomon, M.J. (1996). The cdk-activating kinase (CAK) from budding yeast. Cell 86, 553-564.
35. Kato, J.-Y., Matsuoka, M., Storm, D.K., and Sherr, C.J. (1994a). Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase. Mol. Cell. Biol. 14, 2713-2721.
36. Kip1) of cyclin-dependent kinase 4 activation. Cell 79, 487-496.
37. King, R.W., Deshaies, R.J., Peters, J.-M., and Kirschner, M.W. (1996). How proteolysis drives the cell cycle. Science 274, 1652-1659.
38. MAT1-dependent manner. Mol. Cell. Biol. 17, 7220-7229.
39. MO15 associates with a p36 subunit and requires both nuclear translation and Thr176 phosphorylation to generate cdk-activating kinase activity in Xenopus oocytes. EMBO J. 13, 5155-5164.
40. Larochelle, S., Pandur, J., Fisher, R.P., Salz, H.K., and Suter, B. (1998). Cdk7 is essential for mitosis and for in vivo cdk-activating kinase activity. Genes Dev. 12, 370-381.
41. KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 9, 639-649.
42. WAF-1 gene activities. Mol. Cell. Biol. 16, 1786-1793.
43. Lu, H., Fisher, R.P., Bailey, P., and Levine, A.J. (1997). The cdk7-cycH-p36 complex of transcription factor IIH phosphorylates p53, enhancing its sequence-specific DNA binding activity in vitro. Mol. Cell. Biol. 17, 5923-5934.
44. Mäkelä, T.P., Tassan, J.-P., Nigg, E.A., Frutiger, S., Hughes, G.J., and Weinberg, R.A. (1994). A cyclin associated with the CDK-activating kinase MO15. Nature 371, 254-257.
45. Martinez, A.-M., Afshar, M., Martin, F., Cavadore, J.-C., Labbé, J.-C., and Dorée, M. (1997). Dual phosphorylation of the T-loop in cdk7: its role in controlling cyclin H binding and CAK activity. EMBO J. 16, 343-354.
46. Matsuoka, M., Kato, J.-Y., Fisher, R.P., Morgan, D.O., and Sherr, C.J. (1994). Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase. Mol. Cell. Biol. 14, 7265-7275.
47. CIP1 cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9, 650-662.
48. Morgan, D.O. (1995). Principles of CDK regulation. Nature 374, 131-134.
49. Nasmyth, K. (1993). Control of the yeast cell cycle by the Cdc28 protein kinase. Curr. Opin. Cell Biol. 5, 166-179.
50. Ninomiya-Tsuji, J., Nomoto, S., Yasuda, H., Reed, S.I., and Matsumoto, K. (1991). Cloning of a human cDNA encoding a CDC2-related kinase by complementation of a budding yeast cdc28 mutation. Proc. Natl. Acad. Sci. USA 88, 9006-9010.
51. Phelps, D.E., and Xiong, Y. (1997). Assay for activity of mammalian cyclin D-dependent kinases CDK4 and CDK6. Methods Enzymol. 283, 194-205.
52. Pines, J. (1995). Cyclins and cyclin-dependent kinases: a biochemical view. Biochem. J. 308, 697-711.
53. Kip1, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8, 9-22.
54. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78, 59-66.
55. cdc2. EMBO J. 12, 3123-3132.
56. MO15. J. Cell Sci. 107, 2789-2799.
57. Rochette-Egly, C., Adam, S., Rossignol, M., Egly, J.-M., and Chambon, P. (1997). Stimulation of RARα activation function AF-1 through binding to the general transcription factor TFIIH and phosphorylation by CDK7. Cell 90, 97-107.
58. Rossignol, M., Kolb-Cheynel, I., and Egly, J.-M. (1997). Substrate specificity of the cdk-activating kinase (CAK) is altered upon association with TFIIH. EMBO J. 16, 1628-1637.
59. Roy, R., Adamczewski, J.P., Seroz, T., Vermeulen, W., Tassan, J.-P., Schaeffer, L., Nigg, E.A., Hoeijmakers, J.H.J., and Egly, J.-M. (1994). The MO15 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor. Cell 79, 1093-1101.
60. Russo, A.A. (1997). Purification and reconstitution of cyclin-dependent kinase 2 in four states of activity. Methods Enzymol. 283, 3-12.
61. Kip1 cyclin-dependent kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 382, 325-331.
62. Russo, A.A., Jeffrey, P.D., and Pavletich, N.P. (1996b). Structural basis of cyclin-dependent kinase activation by phosphorylation. Nat. Struct. Biol. 3, 696-700.
63. Serizawa, H., Mäkelä, T.P., Conaway, J.W., Conaway, R.C., Weinberg, R.A., and Young, R.A. (1995). Association of Cdk-activating kinase subunits with transcription factor TFIIH. Nature 374, 280-282.
64. Serrano, M., Hannon, G.J., and Beach, D. (1993). A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704-707.
65. Kip1. Genes Dev. 11, 1464-1478.
66. Sherr, C.J. (1994). G1 phase progression: cycling on cue. Cell 79, 551-555.
67. 1 cyclin-dependent kinases. Genes Dev. 9, 1149-1163.
68. Shiekhattar, R., Mermelstein, F., Fisher, R.P., Drapkin, R., Dynlacht, B., Wessling, H.C., Morgan, D.O., and Reinberg, D. (1995). Cdk-activating kinase complex is a component of human transcription factor TFIIH. Nature 374, 283-287.
69. Solomon, M.J., and Kaldis, P. (1998). Regulation of cdks by phosphorylation. In: Results and Problems in Cell Differentiation: Cell cycle control, vol. 22, ed. M. Pagano, Heidelberg: Springer Verlag, 79-109.
70. cdc2. Cell 63, 1013-1024.
71. MO15. EMBO J. 12, 3133-3142.
72. Tassan, J.-P., Jaquenoud, M., Fry, A.M., Frutiger, S., Hughes, G.J., and Nigg, E.A. (1995). In vitro assembly of a functional human CDK7-cyclin H complex requires MAT1, a novel 36 kDa RING finger protein. EMBO J. 14, 5608-5617.
73. Thuret, J.-Y., Valay, J.-G., Faye, G., and Mann, C. (1996). Civ1 (CAK in vivo), a novel Cdk-activating kinase. Cell 86, 565-576.
74. Toyoshima, H., and Hunter, T. (1994). p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 78, 67-74.
75. van den Heuvel, S., and Harlow, E. (1993). Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262, 2050-2054.
76. Kip1. EMBO J. 16, 5334-5344.
77. Yankulov, K.Y., and Bentley, D.L. (1997). Regulation of CDK7 substrate specificity by MAT1 and TFIIH. EMBO J. 16, 1638-1646.
78. Zheng, J., Knighton, D.R., Ten Eyck, L.F., Karlsson, R., Xuong, N.-H., Taylor, S.S., and Sowadski, J.M. (1993). Crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MgATP and peptide inhibitor. Biochemistry 32, 2154-2161.
79. 14C]benzoyl 5′-adenosine. J. Biol. Chem. 254, 8363-8368.